top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
Aro Biotherapeutics Announces Leadership Transition: Purnanand Sarma, Ph.D., Appointed as CEO
Philadelphia, February 11, 2025 (Business Wire) -- Aro Biotherapeutics is undergoing a leadership transition, with co-founder Susan...
Globus Medical Expands Neuromodulation Footprint with $250M Acquisition of Nevro
Audubon, PA, February 11, 2025 (finance yahoo) -- Globus Medical has signed a definitive agreement to acquire Nevro Corp. in an...
Baxter CEO José Almeida Retires; Brent Shafer Appointed Interim CEO
Deerfield, Ill, February 2, 2025 (Baxter) -- Baxter International announces the retirement of CEO José Almeida, effective immediately,...
Novartis Strengthens Cardiovascular Pipeline with $925M Acquisition of Anthos Therapeutics Acquisition
Boston, MA, and Basel, Switzerland, February 11, 2025 (Novartis) -- Novartis has announced a definitive agreement to acquire Anthos...
Neko Health Secures $260M in Series B Funding to Expand Healthcare Scanner Technology in the U.S. and Europe
Stockholm, Sweden, January 27, 2025 (yahoo finance) -- Neko Health raised $260 million in Series B funding to expand its healthcare...
Lyndra Therapeutics Appoints Adam Sayer as CEO to Drive Innovation in Long-Acting Oral Therapies
Watertown, MA, January 28, 2025 (Business Wire) -- Adam Sayer has been appointed President and CEO of Lyndra Therapeutics, where he...
AbbVie Partners with Neomorph to Develop Novel Molecular Glue Degraders for Cancer and Immune Disorders, with Up to $1.64B in Potential Milestones
North Chicago, IL and San Diego, CA, January 23, 2025 (PRNewswire) -- AbbVie has partnered with Neomorph to develop molecular glue...
Masimo Appoints Katie Szyman as CEO
Irvine, CA, January 21, 2025 (Business Wire) -- Katie Szyman has been appointed CEO of Masimo, bringing significant experience from her...
Zimmer Biomet to Acquire Paragon 28 for $1.1B, Expanding Orthopedic Surgical Portfolio
Warsaw, IN, January 28, 2025 (Reuters) -- Zimmer Biomet is acquiring Paragon 28 for $1.1 billion to expand its orthopedic surgical...
Tune Therapeutics Secures $175M to Advance Epigenetic Silencing Platform into Clinical Trials
Durham, NC and Seattle, WA, January 12, 2025 (Business Wire) -- Tune Therapeutics has raised $175 million in Series B funding to...
Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics
Durham, NC, January 09, 2025 (Globe newswire) -- Ribometrix has appointed Dr. William S. Marshall as CEO and Dr. Katie Warner as CSO,...
Kardigan Debuts with $300M and Visionary Team to Revolutionize Cardiovascular Medicine Through Personalized Therapies
San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure...
City Therapeutics Appoints Andrew Orth as CEO to Propel RNAi Innovation into Clinical Development
Cambridge, MA, January 07, 2025 (Business Wire) -- City Therapeutics, a biopharmaceutical leader in RNA interference (RNAi) medicine,...
Stryker to Acquire Inari Medical in $4.9B Deal, Expanding Leadership in Peripheral Vascular Care
Portage, MI and Irvine, CA, January 06, 2025 (Globe Newswire) -- Stryker’s acquisition of Inari Medical for $4.9 billion reinforces its...
Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants
Germantown, MD, December 27, 2024 (PRNewswire) -- Precigen, Inc. has entered into a securities purchase agreement for the sale of its...
VectorY Therapeutics Appoints Jim Scibetta as CEO and Expands U.S. Presence
Amsterdam, Netherlands and Boston, MA, December 20, 2024 (Business Wire) -- VectorY Therapeutics has appointed Jim Scibetta as its new...
Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline
Cambridge, MA and Oxford, England, December 17, 2024 (Business Wire) -- Akamis Bio secured $60 million in Series A Prime funding and...
Borealis Biosciences Appoints Christian Hordo as CEO and Secures $30M in Series A Extension
Vancouver, British Columbia & Seattle, December 30, 2024 (Business Wire) -- Borealis Biosciences has appointed Christian Hordo as CEO...
AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B
San Francisco, CA, December 26, 2024 (PRNewswire) -- AusperBio has raised $73 million in Series B funding to advance its lead therapy,...
Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants
Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with...
bottom of page